If partnerships, I see good upfront cash and great
Post# of 72440
If cash for whole company now, it would have to be gigantic or Leo will hold out for products to flesh out (how large will P be in dermatology and autoimmune indications, how massive will B prove to be in indications not even being researched yet as it seems to cross many, many boundaries of various medical needs, how complementary a compound will K prove to be for many cancer treatments).
End result is MASSIVE. How we get there we will find out once P results are given and Leo can give some indication of the pathway he (and Drs. B and M) believe will maximize IPIX value.
I believe most numbers I hear thrown around today could prove quite low compared to what the final end value of the company turns out to be. I dare to say that what IPIX has in its pipeline today could be the largest collective trove of new products ever to have been offered by a biotech startup and I believe Leo knows that.